Clinical Application of the Heart Rate Deceleration Capacity Test to Predict Epirubicin-induced Cardiotoxicity

To investigate the clinical value of heart rate deceleration capacity (DC) in predicting the risk of epirubicin-induced cardiotoxicity. METHODS: The CK-MB and cTnI levels and DC values of 86 patients were examined before chemotherapy and again after 2 and 4 cycles of chemotherapy. Patients were divi...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Yan-ying, Yang, Zhi-jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Journal of Cardiovascular Pharmacology 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4598070/
https://www.ncbi.nlm.nih.gov/pubmed/26080056
http://dx.doi.org/10.1097/FJC.0000000000000289

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4598070/
https://www.ncbi.nlm.nih.gov/pubmed/26080056
http://dx.doi.org/10.1097/FJC.0000000000000289

Ejemplares similares